Clinical Trial: Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07642960) titled 'Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization' on June 06.

Brief Summary: The goal of this clinical trial is to evaluate the efficacy and safety of combined fine-needle diathermy and subconjunctival Bevacizumab injection in patients with corneal neovascularization.

The main questions it aims to answer are:

Does combined fine-needle diathermy and subconjunctival Bevacizumab injection promote regression of corneal neovascularization? Is the treatment safe and well tolerated by patients?

Participants will:

Undergo a baseline evaluation, including assessment of disease duration, ocula...